HISTOGENICS CORP's ticker is HSGX and the CUSIP is 43358V109. A total of 30 filers reported holding HISTOGENICS CORP in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $631,000 | +85.6% | 252,498 | +103.8% | 0.00% | – |
| Q1 2018 | $340,000 | +132.9% | 123,896 | +72.8% | 0.00% | – |
| Q4 2017 | $146,000 | +78.0% | 71,706 | +71.1% | 0.00% | – |
| Q3 2017 | $82,000 | +331.6% | 41,900 | +263.5% | 0.00% | – |
| Q4 2016 | $19,000 | +11.8% | 11,528 | +105.9% | 0.00% | – |
| Q3 2016 | $17,000 | +750.0% | 5,600 | +833.3% | 0.00% | – |
| Q4 2015 | $2,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Joseph P. Lucia & Associates, LLC | 991 | $5,730,000 | 0.43% |
| Abingworth LLP | 1,777,778 | $206,000 | 0.18% |
| SABBY MANAGEMENT, LLC | 1,900,100 | $220,000 | 0.11% |
| Rossmore Private Capital | 242,004 | $28,000 | 0.01% |
| Virtu Financial LLC | 592,976 | $69,000 | 0.00% |
| Palo Alto Investors LP | 302,922 | $35,000 | 0.00% |
| Advisor Group, Inc. | 100 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,000 | $0 | 0.00% |
| NORTHERN TRUST CORP | 20,240 | $2,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |